Fourth of July in 2018: A Time of Celebration and Challenges

As we celebrate the nation’s birthday this week, it seems that almost everyone is concerned about challenges that lie ahead, be they personal or on a large scale. Stepping outside, I worry about the increasingly high temperatures in the U.S., as well as in Europe, Latin America, and Asia, where the IMF has recently participated in myeloma meetings. These areas, too, are experiencing some of the hottest days or months on record.

 

Takeaways from ASCO 2018

As the hubbub around ASCO 2018 comes to an end, what are the main takeaways?

For sure, the media blitz distorts the importance of some presentations versus others. In most cases, study results are preliminary, with further follow-up and traditional peer reviews still pending.

Preview of the 9th Annual International Myeloma Working Group (IMWG) Summit

The International Myeloma Foundation (IMF) will host the 9th Annual International Myeloma Working Group (IMWG) Summit from June 11–13 in Stockholm, Sweden. More than 100 of the world’s top myeloma experts will attend the 2018 Summit, which convenes on the eve of the 23rd Annual Congress of the European Hematology Association (EHA), also in Stockholm. Throughout the IMWG Summit, myeloma experts will debate how best to treat patients in 2018 and beyond.

 

Investing in Health Is the Best Way to Achieve Longevity

For most myeloma patients, the idea of good health and longevity may seem like a distant dream. So, why talk about these things? Because, no matter what diagnosis or challenge we’ve been given, most of us still strive to achieve the best health and the longest life possible. Occasionally, that makes us susceptible to purveyors of magic bullets who promise to deliver good health and extended life, based on questionable science. But the good news is there are some very sound ways to achieve both.

 

ASCO 2018: Helpful Guidance, But No Breakthroughs

The abstracts for the 2018 American Society of Clinical Oncology (ASCO) annual meeting next month have just been released. Among the 7 oral presentations, 62 posters, and educational sessions focusing on multiple myeloma, no dramatic new findings are reported. But there are several important updates and helpful discussions to guide practicing clinicians and inform patients.

 

Pages